NCT05019053

Brief Summary

The coronavirus (COVID-19) pandemic is a significant psychological stressor that threatens the onset of a mental health crisis in the US. Fear and anxiety about COVID-19 and its economic impact, as well as loneliness due to the required social isolation, are driving the mental health impacts of COVID-19; in a recent Kaiser Family Foundation poll, 45% of respondents reported that the coronavirus has had a negative impact on their mental health. This is reflected in Southeastern Ohio. In data that the investigators collected from 317 Ohio University faculty, staff, and students from late May to early June, 39% reported moderate-to-severe levels of anxiety, 41% reported moderate-to-severe levels of depression and 57% reported the COVID-19 outbreak was impacting their sense of social connection much or very much. Despite the significant community need for accessible and affordable care, there are currently no evidence-based interventions for individuals coping poorly with coronavirus-related distress. The investigators have developed a virtual group-based intervention targeting cognitive biases that amplify the experience of stress and anxiety (i.e., amplifying cognitions; Coping with Coronavirus-Related Emotion and Worry \[COPING CREW\]). The next step in developing this intervention in a scientifically rigorous manner is to refine the manual and procedures and conduct a pilot test of the intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

February 18, 2022

Status Verified

February 1, 2022

Enrollment Period

9 months

First QC Date

July 29, 2021

Last Update Submit

February 16, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Satisfaction with the intervention as assessed by Client Satisfaction Questionnaire-8

    The Client Satisfaction Questionnaire-8 is a 8-item self-report scale that assesses client satisfaction with a particular intervention/program. The Client Satisfaction Questionnaire-8 is completed by rating satisfaction with services on a 1-4 Likert-type scale. Possible total scores range from 8 to 32. Greater satisfaction is indicated by higher scores.

    Immediately after the intervention

  • Feasibility of service as assessed by response rates for the Ecological Momentary Assessment/Ecological Momentary Intervention component of the intervention

    Feasibility will also be determined based on response rates for Ecological Momentary Assessment/Ecological Momentary Intervention. If 80% of participants respond to 80% of the EMA prompts, this will be considered a feasible means of service delivery.

    5-week EMA/EMI, During the Intervention (Weeks 1-5)

Secondary Outcomes (65)

  • COVID-19 Impact Battery - Behavior

    Baseline, pre-intervention

  • COVID-19 Impact Battery - Behavior

    Immediately after the intervention

  • COVID-19 Impact Battery - Behavior

    Follow-Up, 1 month after the intervention

  • COVID-19 Impact Battery - Behavior

    Follow-Up, 3 months after the intervention

  • COVID-19 Impact Battery - Worry

    Baseline, pre-intervention

  • +60 more secondary outcomes

Study Arms (1)

Coping Crew Intervention

EXPERIMENTAL

Interested participants who meet the screening criteria will be assigned to receive COPING CREW. First, following informed consent, eligible participants will complete a baseline assessment appointment in the week prior to the group beginning. During the baseline appointment, participants will provide informed consent, be instructed in the use of Microsoft Teams, complete a battery of self-report measures, be given a semi-structured diagnostic interview, and follow instructions to install a mobile app that will be used to track their mood and homework. Then, 4 groups of COPING CREW, with 6 participants per group, will be run. Participants will complete four weekly 60-minute virtual intervention sessions followed by a booster session two weeks later. Participants will complete daily surveys and homework assignments on their mobile devices. Links to follow-up surveys will be sent to participants at 1- and 3-month follow-ups.

Behavioral: Coping Crew

Interventions

Coping CrewBEHAVIORAL

Coping Crew consists of five 60-minute virtual intervention sessions coinciding with five weeks of EMI. Participants will receive psychoeducation, challenge cognitive biases or mythbust, and participate in behavioral exposure and behavioral experiments. An EMI component of this treatment will be included for the purpose of treatment monitoring and homework tracking. Participation in this EMI component involves the daily report of levels of anxiety, depression, stress, and loneliness. When participants endorse elevated levels on any of these constructs, they will receive a targeted message reminding them of the topics covered in COPING CREW. One month after the intervention session, COPING CREW participants will complete follow-up questionnaires and interview. Participants will also participate in a feedback session 3 months after the intervention.

Coping Crew Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elevated anxiety sensitivity (i.e., a score greater than 1 standard deviation above the mean on the Anxiety Sensitivity Index-3; Taylor et al., 2007)
  • Elevated Intolerance of uncertainty (i.e., a score greater than 1 standard deviation above the mean on the Intolerance of Uncertainty Scale - Short Form; Carleton et al., 2007)
  • Elevated loneliness (i.e., a score greater than 1 standard deviation above the mean on the NIH Toolbox Loneliness Scale; Cyranowski et al., 2013)
  • Access to a device with internet connection

You may not qualify if:

  • Participants who have previously received other FEAR Lab interventions or participated in a focus group related to that intervention (20-X-184; 20-X-204) will be excluded due to the overlap of intervention material.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio University

Athens, Ohio, 45701, United States

RECRUITING

Related Publications (33)

  • Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM. 2020 Oct 1;113(10):707-712. doi: 10.1093/qjmed/hcaa202.

    PMID: 32539153BACKGROUND
  • Czeisler ME, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, Czeisler CA, Howard ME, Rajaratnam SMW. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. doi: 10.15585/mmwr.mm6932a1.

    PMID: 32790653BACKGROUND
  • Mohr DC, Hart SL, Howard I, Julian L, Vella L, Catledge C, Feldman MD. Barriers to psychotherapy among depressed and nondepressed primary care patients. Ann Behav Med. 2006 Dec;32(3):254-8. doi: 10.1207/s15324796abm3203_12.

    PMID: 17107299BACKGROUND
  • Brenes GA, Danhauer SC, Lyles MF, Hogan PE, Miller ME. Barriers to Mental Health Treatment in Rural Older Adults. Am J Geriatr Psychiatry. 2015 Nov;23(11):1172-8. doi: 10.1016/j.jagp.2015.06.002. Epub 2015 Jun 17.

    PMID: 26245880BACKGROUND
  • Mohr DC, Ho J, Duffecy J, Baron KG, Lehman KA, Jin L, Reifler D. Perceived barriers to psychological treatments and their relationship to depression. J Clin Psychol. 2010 Apr;66(4):394-409. doi: 10.1002/jclp.20659.

    PMID: 20127795BACKGROUND
  • DeMartini KS, Carey KB. The role of anxiety sensitivity and drinking motives in predicting alcohol use: a critical review. Clin Psychol Rev. 2011 Feb;31(1):169-77. doi: 10.1016/j.cpr.2010.10.001. Epub 2010 Oct 21.

    PMID: 21074306BACKGROUND
  • McClelland H, Evans JJ, Nowland R, Ferguson E, O'Connor RC. Loneliness as a predictor of suicidal ideation and behaviour: a systematic review and meta-analysis of prospective studies. J Affect Disord. 2020 Sep 1;274:880-896. doi: 10.1016/j.jad.2020.05.004. Epub 2020 May 22.

    PMID: 32664029BACKGROUND
  • Allan NP, Macatee RJ, Norr AM, Raines AM, Schmidt NB. Relations between common and specific factors of anxiety sensitivity and distress tolerance and fear, distress, and alcohol and substance use disorders. J Anxiety Disord. 2015 Jun;33:81-9. doi: 10.1016/j.janxdis.2015.05.002. Epub 2015 May 21.

    PMID: 26037492BACKGROUND
  • Allan NP, Capron DW, Raines AM, Schmidt NB. Unique relations among anxiety sensitivity factors and anxiety, depression, and suicidal ideation. J Anxiety Disord. 2014 Mar;28(2):266-75. doi: 10.1016/j.janxdis.2013.12.004. Epub 2013 Dec 27.

    PMID: 24534564BACKGROUND
  • Allan NP, Albanese BJ, Norr AM, Zvolensky MJ, Schmidt NB. Effects of anxiety sensitivity on alcohol problems: evaluating chained mediation through generalized anxiety, depression and drinking motives. Addiction. 2015 Feb;110(2):260-8. doi: 10.1111/add.12739. Epub 2014 Oct 23.

    PMID: 25220033BACKGROUND
  • Banducci AN, Bujarski SJ, Bonn-Miller MO, Patel A, Connolly KM. The impact of intolerance of emotional distress and uncertainty on veterans with co-occurring PTSD and substance use disorders. J Anxiety Disord. 2016 Jun;41:73-81. doi: 10.1016/j.janxdis.2016.03.003. Epub 2016 Mar 9.

    PMID: 27004450BACKGROUND
  • Allan NP, Boffa JW, Raines AM, Schmidt NB. Intervention related reductions in perceived burdensomeness mediates incidence of suicidal thoughts. J Affect Disord. 2018 Jul;234:282-288. doi: 10.1016/j.jad.2018.02.084. Epub 2018 Feb 27.

    PMID: 29554617BACKGROUND
  • Oglesby ME, Allan NP, Schmidt NB. Randomized control trial investigating the efficacy of a computer-based intolerance of uncertainty intervention. Behav Res Ther. 2017 Aug;95:50-57. doi: 10.1016/j.brat.2017.05.007. Epub 2017 May 11.

    PMID: 28531873BACKGROUND
  • Raines AM, Allan NP, McGrew SJ, Gooch CV, Wyatt M, Laurel Franklin C, Schmidt NB. A computerized anxiety sensitivity intervention for opioid use disorders: A pilot investigation among veterans. Addict Behav. 2020 May;104:106285. doi: 10.1016/j.addbeh.2019.106285. Epub 2020 Jan 7.

    PMID: 32006788BACKGROUND
  • Schmidt NB, Capron DW, Raines AM, Allan NP. Randomized clinical trial evaluating the efficacy of a brief intervention targeting anxiety sensitivity cognitive concerns. J Consult Clin Psychol. 2014 Dec;82(6):1023-33. doi: 10.1037/a0036651. Epub 2014 May 12.

    PMID: 24821096BACKGROUND
  • Short NA, Boffa JW, King S, Albanese BJ, Allan NP, Schmidt NB. A randomized clinical trial examining the effects of an anxiety sensitivity intervention on insomnia symptoms: Replication and extension. Behav Res Ther. 2017 Dec;99:108-116. doi: 10.1016/j.brat.2017.09.013. Epub 2017 Oct 5.

    PMID: 29035703BACKGROUND
  • Albanese BJ, Macatee RJ, Allan NP, Short NA, Norr AM, Schmidt NB. Interactive Effects of Anxiety Sensitivity and Attentional Control on Posttraumatic Stress in Community and Clinical Populations. Psychiatry. 2018 Spring;81(1):71-84. doi: 10.1080/00332747.2017.1309867. Epub 2018 Mar 22.

    PMID: 29565729BACKGROUND
  • Raines AM, Boffa JW, Allan NP, Short NA, Schmidt NB. Hoarding and eating pathology: the mediating role of emotion regulation. Compr Psychiatry. 2015 Feb;57:29-35. doi: 10.1016/j.comppsych.2014.11.005. Epub 2014 Nov 6.

    PMID: 25440599BACKGROUND
  • Raines AM, Short NA, Sutton CA, Oglesby ME, Allan NP, Schmidt NB. Obsessive-compulsive symptom dimensions and insomnia: The mediating role of anxiety sensitivity cognitive concerns. Psychiatry Res. 2015 Aug 30;228(3):368-72. doi: 10.1016/j.psychres.2015.05.081. Epub 2015 Jun 28.

    PMID: 26162661BACKGROUND
  • Knapp AA, Feldner M, Allan NP, Schmidt NB, Keough ME, Leen-Feldner EW. Test of an Anxiety Sensitivity Amelioration Program for at-risk youth (ASAP-Y). Behav Res Ther. 2020 Mar;126:103544. doi: 10.1016/j.brat.2019.103544. Epub 2020 Jan 2.

    PMID: 31981802BACKGROUND
  • Glenn D, Golinelli D, Rose RD, Roy-Byrne P, Stein MB, Sullivan G, Bystritksy A, Sherbourne C, Craske MG. Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement. J Consult Clin Psychol. 2013 Aug;81(4):639-649. doi: 10.1037/a0033403. Epub 2013 Jun 10.

    PMID: 23750465BACKGROUND
  • Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA. The Client Satisfaction Questionnaire-8: Psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment. Drug Alcohol Rev. 2018 Jan;37(1):79-86. doi: 10.1111/dar.12522. Epub 2017 May 7.

    PMID: 28480521BACKGROUND
  • Taylor S, Zvolensky MJ, Cox BJ, Deacon B, Heimberg RG, Ledley DR, Abramowitz JS, Holaway RM, Sandin B, Stewart SH, Coles M, Eng W, Daly ES, Arrindell WA, Bouvard M, Cardenas SJ. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. Psychol Assess. 2007 Jun;19(2):176-88. doi: 10.1037/1040-3590.19.2.176.

    PMID: 17563199BACKGROUND
  • Carleton RN, Norton MA, Asmundson GJ. Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. J Anxiety Disord. 2007;21(1):105-17. doi: 10.1016/j.janxdis.2006.03.014. Epub 2006 May 2.

    PMID: 16647833BACKGROUND
  • Cyranowski JM, Zill N, Bode R, Butt Z, Kelly MA, Pilkonis PA, Salsman JM, Cella D. Assessing social support, companionship, and distress: National Institute of Health (NIH) Toolbox Adult Social Relationship Scales. Health Psychol. 2013 Mar;32(3):293-301. doi: 10.1037/a0028586.

    PMID: 23437856BACKGROUND
  • Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011 May;45(5):626-9. doi: 10.1016/j.jpsychires.2010.10.008. Epub 2010 Oct 28.

    PMID: 21035130BACKGROUND
  • Panchal, N. R. K. C. R. L. C., Kamal, R., Orgera, K., Cox, C., Garfield, R., Hamel, L., ... & Chidambaram, P. (2020). The implications of COVID-19 for mental health and substance use. KFF.

    BACKGROUND
  • NW 1615 L. St, Suite 800Washington, Inquiries D 20036USA202-419-4300 | M-857-8562 | F-419-4372 | M. Demographics of Mobile Device Ownership and Adoption in the United States. Pew Research Center: Internet, Science & Tech. Accessed June 12, 2020. https://www.pewresearch.org/internet/fact-sheet/mobile/

    BACKGROUND
  • Barlow DH, Craske MG. Mastery of Your Anxiety and Panic. Oxford University Press; 2006.

    BACKGROUND
  • Cully JA, Teten AL. A therapist's guide to brief cognitive behavioral therapy. Houst Dep Veterans Aff South Cent MIRECC. Published online 2008.

    BACKGROUND
  • Thase ME, Callan JA. The role of homework in cognitive behavior therapy of depression. J Psychother Integr. 2006;16(2):162-177. doi:10.1037/1053-0479.16.2.162

    BACKGROUND
  • Sheehan D, Janavs J, Baker R, Sheehan KH, Knapp E, Sheehan M. Mini International Neuropsychiatric Interview-Version 7.0. 0 DSM-5. 2014.; 2015.

    BACKGROUND
  • Kinser PA, Robins JL. Control group design: enhancing rigor in research of mind-body therapies for depression. Evid Based Complement Alternat Med. 2013;2013:140467. doi: 10.1155/2013/140467. Epub 2013 Apr 7.

    PMID: 23662111BACKGROUND

MeSH Terms

Conditions

Social Isolation

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Central Study Contacts

Nicholas Allan, Ph.D.

CONTACT

Catherine Accorso, M.A.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Psychology

Study Record Dates

First Submitted

July 29, 2021

First Posted

August 24, 2021

Study Start

September 1, 2021

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

February 18, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations